Novo Nordisk Videos

 

Our portfolio (03:27)

Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer of Novo Nordisk, discusses how innovation drives our portfolio. A unique combination of chemical and protein engineering competencies allows our scientists to design new treatments that address the unmet needs of people living with chronic diseases like diabetes, haemophilia and autoimmune inflammatory diseases.
Download video

Other videos in this category